Succinate dehydrogenase-deficient renal cell carcinoma: A retrospective study, 1999–2018
South African Journal of Oncology, 2023 Background: Succinate dehydrogenase-deficient (SDH-deficient) renal cell carcinoma (RCC) is a rare subtype of RCC. Approximately 0.05% – 0.2% of RCCs are SDH-deficient. It is usually associated with a pathogenic germline variant of the enzyme.
Ella Morrison +5 more
doaj +1 more source
Utilisation of wheat bran as a substrate for bioethanol production using recombinant cellulases and amylolytic yeast [PDF]
, 2015 Wheat bran, generated from the milling of wheat, represents a promising feedstock for the production of bioethanol. This substrate consists of three main components: starch, hemicellulose and cellulose.
Basaglia, Marina +6 more
core +1 more source
Human Vaccines & Immunotherapeutics, 2021 Introduction To deliver specific antigens in tumor immunotherapy, tumor cell lysates are commonly used to sensitize dendritic cells (DCs). However, the lysates possess low immunogenicity and contain many types of non-tumor-related antigens, which may ...
Heran Ma +7 more
doaj +1 more source
Renal cell carcinoma: a nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours [PDF]
, 2016 Aim To develop a nomogram from clinical and computed tomography (CT) data for pre-treatment identification of indolent renal cortical tumours. Patients and methods A total of 1201 consecutive patients underwent dedicated contrast-enhanced CT prior to ...
Asnis-Alibozek +15 more
core +1 more source
Study on the effect of Shahin-Dezh green Tuff on the mechanical characteristics of roller compact concrete [PDF]
Journal of Structural and Construction Engineering, 2016 Due to the growing popularity of concrete structure and increasing use of them, especially Roller compacted concrete, applying Pozzolan and replacing cement with Pozzolan is very important.
Sadegh Dardaei +2 more
doaj +1 more source
Tumor Biology, 2017 Imatinib mesylate, a BCR/ABL fusion protein inhibitor, is the first-line treatment against chronic myelogenous leukemia. In spite of its advantageous viewpoints, imatinib still has genuine impediments like undesirable side effects and tumor resistance ...
Alphy Rose James +9 more
doaj +1 more source
Autophagy as a Vital Therapy Target for Renal Cell Carcinoma
Frontiers in Pharmacology, 2021 Autophagy is a process that degrades and recycles superfluous organelles or damaged cellular contents. It has been found to have dual functions in renal cell carcinoma (RCC).
Ying-hua He, Guo Tian
doaj +1 more source
Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes [PDF]
, 2007 Adhesion molecules of the integrin beta1 family are thought to be involved in the malignant progression renal cell carcinoma (RCC). Still, it is not clear how they contribute to this process.
Achiwa H +10 more
core +1 more source
Structure Modification of Quinine on C-9 Hydroxyl Group via Esterification Reaction [PDF]
Journal of Pure and Applied Chemistry Research, 2020 Concept the role played by modified quinine in the asymmetric hydroxyl group inspired studies of modified quinine as chiral organic that lead to drug discovery development.
Teni Ernawati +2 more
doaj
Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells. [PDF]
, 2017 Renal cell carcinoma (RCC) is a deadly malignancy due to its tendency to metastasize and resistance to chemotherapy. Stem-like tumor cells often confer these aggressive behaviors.
Dai, Jin +10 more
core +3 more sources